FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022604135> ?p ?o ?g. }

• W2022604135 endingPage "1182" @default.
• W2022604135 startingPage "1173" @default.
• W2022604135 abstract "Thiazolidinediones represent an established class of insulin sensitizing agents for treating noninsulin-dependent diabetes mellitus. Darglitazone, a thiazolidinedione approximately 200x more potent than ciglitazone, was evaluated in preclinical safety assessment studies using rats (1, 5, and 50 mg/kg/day) and cynomolgus monkeys (50, 75, and 100 mg/kg/day). Darglitazone was a potent adipogenic agent in rats, causing hyperplastic/hypertrophic changes and firmness of white and perirenal, dorsal thoracic (TBAT), and interscapular brown adipose tissue (BAT). Progressive changes in BAT size, morphology, firmness, and fatty acid composition preceded clinical signs of impaired respiration and the subsequent development of a dose-dependent, life-threatening hydrothorax. The characteristics of the pleural effusate were consistent with lymphatic fluid. These adverse effects were ameliorated/reversed upon drug withdrawal and were insulin-dependent since rats rendered totally insulinopenic by streptozotocin pretreatment did not develop TBAT changes or hydrothorax. Although the effects of darglitazone on BAT changes were consistent with enhanced sensitivity to endogenous glucocorticoids, adrenalectomy, and dietary dehydroepiandrosterone administration were without a protective effect. Treated monkeys also developed white and BAT hyperplasia/hypertrophy, peripheral edema, and hydrothorax-related morbidity/mortality. Both species developed reversible, dose-related reductions in red blood cell parameters and follicular atresia. Peripheral and pulmonary edema are purportedly a multifactorial process involving vasodilatation, increased endothelial permeability, and/or plasma volume expansion due to reduced renal sodium excretion. Moreover, profound alterations in TBAT hypertrophy/hyperplasia/firmness may lead to discrete hydrothorax by restricting normal thoracic lymphatic drainage. Similar effects on adipose tissue, hemodilution, and edema (peripheral and pulmonary) were observed clinically with darglitazone and/or several other structurally similar/dissimilar PPAR-gamma agonists." @default.
• W2022604135 created "2016-06-24" @default.
• W2022604135 creator A5000702151 @default.
• W2022604135 creator A5022171156 @default.
• W2022604135 creator A5037161044 @default.
• W2022604135 creator A5038826154 @default.
• W2022604135 creator A5043835042 @default.
• W2022604135 creator A5048903394 @default.
• W2022604135 creator A5053466244 @default.
• W2022604135 date "2003-03-06" @default.
• W2022604135 modified "2023-09-26" @default.
• W2022604135 title "Mechanism and Implications of Brown Adipose Tissue Proliferation in Rats and Monkeys Treated with the Thiazolidinedione Darglitazone, a Potent Peroxisome Proliferator-Activated Receptor-γ Agonist" @default.
• W2022604135 cites W103142017 @default.
• W2022604135 cites W1965687065 @default.
• W2022604135 cites W1965935098 @default.
• W2022604135 cites W1971391868 @default.
• W2022604135 cites W1980136960 @default.
• W2022604135 cites W1980270769 @default.
• W2022604135 cites W1984045042 @default.
• W2022604135 cites W1998974642 @default.
• W2022604135 cites W1999236387 @default.
• W2022604135 cites W2007570209 @default.
• W2022604135 cites W2013678045 @default.
• W2022604135 cites W2034280739 @default.
• W2022604135 cites W2035458523 @default.
• W2022604135 cites W2047591801 @default.
• W2022604135 cites W2066129135 @default.
• W2022604135 cites W2081249638 @default.
• W2022604135 cites W2099316370 @default.
• W2022604135 cites W2124084557 @default.
• W2022604135 cites W2138289723 @default.
• W2022604135 cites W2140603676 @default.
• W2022604135 cites W2142838476 @default.
• W2022604135 cites W2158732171 @default.
• W2022604135 cites W2159270178 @default.
• W2022604135 cites W2167757613 @default.
• W2022604135 cites W2346202365 @default.
• W2022604135 cites W2461330112 @default.
• W2022604135 cites W4231759853 @default.
• W2022604135 cites W4235573080 @default.
• W2022604135 cites W4252969106 @default.
• W2022604135 cites W4296989265 @default.
• W2022604135 cites W4300792843 @default.
• W2022604135 doi "https://doi.org/10.1124/jpet.102.042648" @default.
• W2022604135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12626651" @default.
• W2022604135 hasPublicationYear "2003" @default.
• W2022604135 type Work @default.
• W2022604135 sameAs 2022604135 @default.
• W2022604135 citedByCount "32" @default.
• W2022604135 countsByYear W20226041352012 @default.
• W2022604135 countsByYear W20226041352013 @default.
• W2022604135 countsByYear W20226041352015 @default.
• W2022604135 countsByYear W20226041352016 @default.
• W2022604135 countsByYear W20226041352017 @default.
• W2022604135 countsByYear W20226041352018 @default.
• W2022604135 countsByYear W20226041352020 @default.
• W2022604135 countsByYear W20226041352021 @default.
• W2022604135 countsByYear W20226041352023 @default.
• W2022604135 crossrefType "journal-article" @default.
• W2022604135 hasAuthorship W2022604135A5000702151 @default.
• W2022604135 hasAuthorship W2022604135A5022171156 @default.
• W2022604135 hasAuthorship W2022604135A5037161044 @default.
• W2022604135 hasAuthorship W2022604135A5038826154 @default.
• W2022604135 hasAuthorship W2022604135A5043835042 @default.
• W2022604135 hasAuthorship W2022604135A5048903394 @default.
• W2022604135 hasAuthorship W2022604135A5053466244 @default.
• W2022604135 hasConcept C126322002 @default.
• W2022604135 hasConcept C134018914 @default.
• W2022604135 hasConcept C151955695 @default.
• W2022604135 hasConcept C171089720 @default.
• W2022604135 hasConcept C2776923340 @default.
• W2022604135 hasConcept C2777180221 @default.
• W2022604135 hasConcept C2780642333 @default.
• W2022604135 hasConcept C2780886150 @default.
• W2022604135 hasConcept C555293320 @default.
• W2022604135 hasConcept C71924100 @default.
• W2022604135 hasConceptScore W2022604135C126322002 @default.
• W2022604135 hasConceptScore W2022604135C134018914 @default.
• W2022604135 hasConceptScore W2022604135C151955695 @default.
• W2022604135 hasConceptScore W2022604135C171089720 @default.
• W2022604135 hasConceptScore W2022604135C2776923340 @default.
• W2022604135 hasConceptScore W2022604135C2777180221 @default.
• W2022604135 hasConceptScore W2022604135C2780642333 @default.
• W2022604135 hasConceptScore W2022604135C2780886150 @default.
• W2022604135 hasConceptScore W2022604135C555293320 @default.
• W2022604135 hasConceptScore W2022604135C71924100 @default.
• W2022604135 hasIssue "3" @default.
• W2022604135 hasLocation W20226041351 @default.
• W2022604135 hasLocation W20226041352 @default.
• W2022604135 hasOpenAccess W2022604135 @default.
• W2022604135 hasPrimaryLocation W20226041351 @default.
• W2022604135 hasRelatedWork W1957106181 @default.
• W2022604135 hasRelatedWork W1965875712 @default.
• W2022604135 hasRelatedWork W2025731911 @default.
• W2022604135 hasRelatedWork W2036460863 @default.
• W2022604135 hasRelatedWork W2045205233 @default.
• W2022604135 hasRelatedWork W2048236996 @default.
• W2022604135 hasRelatedWork W2125340464 @default.

• next